Abstract 1880: A novel CD137 agonist exhibits potent antitumor efficacy with a good safety profile
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-1880
Abstract: Background: CD137 (TNFRSF9, 4-1BB) is a member of the tumor necrosis factor receptor superfamily that functions as a costimulatory molecule of immunocytes and is mainly expressed on the surface of immune cells including activated T… read more here.
Keywords: safety; zg033; efficacy; cd137 agonist ... See more keywords